Paying for Gene Therapy, CRISPR in People, RNAi at “What’s Hot” on May 16 – Xconomy
Xconomy |
Paying for Gene Therapy, CRISPR in People, RNAi at “What's Hot” on May 16
Xconomy The first U.S. gene therapy, for a rare form of vision loss, is now on the market. In 2017, the FDA also approved the first two CAR-T cell therapies for cancer, the first cancer drug based on a genetic signature, and the first smartphone app to treat … |
